Baxter Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-01-30
Share capital
25 783 000,00 PLN
Activity description

Baxter Polska operates in medical technology, offering advanced systems, medicines and infusion technologies for hospital care. The company also offers parenteral nutrition solutions, and Hillrom is part of Baxter.

Registered address
Kruczkowskiego 8, 00-380 Warszawa, Poland
Website
baxter.com.plWebsite active
Email
Email warning
Phone
Social media
Electronic delivery address
AE:PL-16382-73049-HJRVE-29

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 70.73mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 5.95mMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 62.93mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 82.74mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 2004-05-31. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 301.9K

MSiG notices

Publication dateEvent
Nov 15, 2016Commercial Companies Code notice

Public aid

No public aid cases recorded in the last 10 years.

Tenders

2556 tenders recorded as contractor: 805 national ($32,457,218) and 1751 EU ($5,071,161,638).

SubjectAmount
Zakup i dostawa sprzętu medycznego jednorazowego użytku z zakresu anestezjologii na bieżące potrzeby Uniwersyteckiego Szpitala Klinicznego w Opolu.
–
Dostawa materiałów jednorazowych do SPZOZ w Choszcznie
–
„Dostawa produktów leczniczych, płynów infuzyjnych i produktów do żywienia pozajelitowego dla pacjentów szpzoz im. Dzieci Warszawy w Dziekanowie Leśnym”
–

Public sector contracts

Baxter Polska is the contractor in 453 public sector contracts, worth PLN 86.78m in total. They were signed with 170 public buyers. The largest number (14) were signed with Uniwersytecki Szpital Kliniczny w Poznaniu.

Public buyerValue
Zespół Opieki Zdrowotnej w OławiePLN 273,392
Szpital Dziecięcy Im. Prof. Dr Med. Jana Bogdanowicza Samodzielny Publiczny Zakład Opieki ZdrowotnejPLN 4,400
Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza w BydgoszczyPLN 1,359,225
Specjalistyczny Szpital Im. E. Szczeklika w TarnowiePLN 1,000
Uniwersytecki Szpital Kliniczny Nr 4 w LubliniePLN 6,540

Public procurement disputes (KIO)

Baxter Polska has been a party to 33 cases before the National Appeal Chamber (since 2011). It filed 29 appeals (15 upheld, 2 dismissed, 9 discontinued). In 4 cases it joined the proceedings as a participant.

DateCase no.RoleOther partyOutcome
Jun 12, 2026KIO 1987/26AppellantSamodzielny Publiczny Wojewódzki Szpital Zespolony w SzczecinieDiscontinued
May 25, 2026KIO 2242/26Appellant4 Wojskowy Szpital Kliniczny z Polikliniką – Samodzielny Publiczny Zakład Opieki Zdrowotnej we WrocławiuDiscontinued
Oct 21, 2024KIO 3574/24AppellantWielospecjalistyczny Szpital Miejski im. dr Emila Warmińskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej z siedzibą w BydgoszczyUpheld
Jun 21, 2024KIO 1874/24AppellantBiałostockie Centrum Onkologii im. Marii Skłodowskiej-Curie w Białymstoku–
May 23, 2024KIO 1630/24AppellantSamodzielny Publiczny Szpital Specjalistyczny Szpital Zachodni im. Św. Jana Pawła II w Grodzisku Mazowieckim–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Piotr Adam Leszczyński – Attorney-in-fact (joint)
Justyna Ewa Betta – Attorney-in-fact (joint)
Ewelina Marta Chmielewska – Attorney-in-fact (joint)
Ewa Orman – Management Board Member
Michał Gryglewski – Attorney-in-fact (joint)

Manner of representation

Two members of the management board jointly, or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Baxter Bv
8,879$2,398,433.2834.4374%
Baxter World Trade Corporation
16,904$4,566,180.4465.5626%

Beneficial owners

Person

Competitors

Name
Bialmedsp. z o.o.
Roche Diagnostics Polskasp. z o.o.
Gilead Sciences Polandsp. z o.o.
Abbott Medicalsp. z o.o.
LubfarmS.A.
Olympus Polskasp. z o.o.
Hammermed Medical PolskaS.K.A.
Chiesi Polandsp. z o.o.
Fresenius Medical Care PolskaS.A.
Perrigo Polandsp. z o.o.

Change history

DateEvent
2026-09-01Share capital change
2016-07-29Share capital change
2015-05-13PKD change
2008-06-30Share capital change
2008-06-30Name change

FAQ

Last updated: 2026-10-13